Hexo’s (TSX:HEXO) $70 Million Financing Is Too Little, Too Late

Hexo Corp recently announced that it is delaying its Q4 2019 earnings report amid a $70 million financing. Is financing a little too late to the party?

| More on:
Bad apple with good apples

Image source: Getty Images

Initially scheduled for October 24, 2019, Hexo (TSX:HEXO)(NYSE:HEXO) has delayed its fourth-quarter earnings report. Hexo announced a $70 million private placement of convertible debentures led by a group of private investors, including the company’s CEO, Sebastian St-Louis. What does this delay mean for you as an investor? Does this mean good or bad news?

Let us take a look at the situation to determine whether or not you should have a vested interest in Hexo shares if you are an avid investor in the pot industry.

Hexo share price scare continues

For those of you following weed stocks, you already know how alarming the situation is with the overall pot industry. Hexo continues to be alarming for investors recently, and the scares do not seem to end. The stock lost a massive 13.61% value in share price since the past week. Trading at $3.11 at the time of writing, Hexo is down a massive 72% from its 52-week high of $10.44 per share.

The disastrous run for the company continues to worsen, and the latest news is that the company postponed its Q4 2019 earnings report. Pushed back to October 28, 2019, the announcement of a $70 million financing program is grabbing everybody’s attention. What does the $70 million financing through convertible debentures entail?

Financing to steady the ship

According to Hexo’s CEO, this $70 million private placement is going to exhibit precisely how confident the company itself is about the value it can bring to shareholders. The group of investors consists of the CEO himself as well as other board members Vincent Chiara, Nathalie Bourque, Adam Miron, and Dr. Michael Munzar.

The company intends to use proceeds from this private placement for the company’s general corporate purposes as well as working capital. If you think about it, the company is putting its money where its mouth is. Securing capital at such a large scale from its top brass should provide investors with a boost in confidence about the company. At least that is what I think Hexo’s intent is.

The convertible debentures are expected to mature three years from the issuance date. After closing, the debentures will bear 8% interest. After a year, the holders will have the option of converting them into regular Hexo shares for $3.16. The fact that the shareholders agreed to conversion at the close to the 52-week low is slightly alarming.

The company reduced its net forecast for the Q4 2019 earnings to around $14.5 million and $16.5 million — $26 million lower than what Hexo previously signaled. Combined with the fact that Hexo withdrew its 2020 financial outlook, which the company announced in June, is also alarming.

Original Stash

The only thing that might offset this news is the announcement of a low-cost brand, Original Stash. This new brand is an attempt by Hexo to counter the black market’s devastating effects on the legal pot industry. Sebastian St-Louis stated that the company’s aim with Original Stash is to disrupt the illegal weed market.

The company intends to educate consumers about the importance and actual value of products that are tested and regulated. One of the reasons why the illicit cannabis industry has the upper hand over the legal counterpart is due to the pricing. The move is another promising sign for investors.

Foolish takeaway

The bloodshed continues for the overall pot industry, and Hexo does not seem well insulated against the horrors. The $70 million should add to the $188 million in cash on hand for Hexo to improve its situation in the short term. I feel that the positives of the current situation are not strong enough to outweigh the negatives.

I feel that the $70 million is coming in a little too late. If the private investment group from within Hexo’s ranks was so confident about the company’s situation improving, investors should not have agreed on a conversion near the company’s 52-week lows. I think you should be wary of Hexo shares right now and wait for it to at least bottom out.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned.

More on Cannabis Stocks

Upwards momentum
Energy Stocks

3 Canadian Stocks That Could be Huge Winners in the Next Decade and Beyond

Stocks like Canopy Growth, Blackberry, and Ballard Power are leading and redefining new multi-billion dollar industries.

Read more »

A cannabis plant grows.
Cannabis Stocks

Should You Invest in Canadian Cannabis Stocks Like Canopy Growth in September?

Canadian cannabis stocks, including Canopy Growth, remain high-risk bets for investors, despite trading 94% below all-time highs.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

ACB Stock: What’s Behind Aurora Cannabis’ Recent Surge?

More countries are legalizing marijuana. Should you buy ACB stock?

Read more »

data analytics, chart and graph icons with female hands typing on laptop in background
Cannabis Stocks

Got $5,000? 3 Stocks to Hold for the Next 20 Years

Long-term investors can consider buying shares of Dollarama and Curaleaf to generate market-beating gains in the next two decades.

Read more »

A cannabis plant grows.
Cannabis Stocks

Is Now the Time to Buy Cannabis Stocks?

These cannabis stocks are up 70% and 19% this month! Should Canadian investors hop on board?

Read more »

A cannabis plant grows.
Cannabis Stocks

Why I’m Considering Canopy Growth Stock For My RRSP

As the cannabis industry grows, adding Canopy Growth stock to my RRSP will give me access to massive upside.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock Jumps 20%: Here’s What Happened

Canopy Growth stock (TSX:WEED)(NASDAQ:CGC) popped 20% on Monday from an announcement made by another cannabis producer.

Read more »

Retirement plan
Dividend Stocks

4 Stocks That Could Turn $100,000 Into $500,000 by the Time You Retire

Companies such as Brookfield Asset Management have the potential to consistently beat the broader markets and deliver stellar returns to…

Read more »